LBF20208PG01: Difference between revisions

Latest revision as of 17:52, 21 October 2010

Upper classes: LB LBF

δ12- Prostaglandin D₂

Structural Information
	(9α,15S) -Dihydroxy-11-oxo-prosta- (cis-5,trans-12) -dien-1-oic acid
	δ12- Prostaglandin D₂ (9α,15S) -Dihydroxy-11-oxo-prosta- (5Z,12E) -dien-1-oic acid

Formula	C20H32O5
Exact Mass	352.224974134
Average Mass	352.46508
SMILES	`C(CC[C@H](O)CC=C([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)CC`
Physicochemical Information









	delta 12-PGD2 is catalyzed to delta 12-PGJ2, which has antimitotic and carcinogenic activities. Kato_T et al. Fukushima_M


Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

Reported Metabolites, References

Biospecies	ID	Compound Name	Reference	Comment
n.a.	LBF20208PG01	See above.	Fukushima_M 1990
n.a.	LBF20208PG01	See above.	Kato_T et al. 1986

@@ Line 1: / Line 1: @@
+{{Lipid/Header}}
 {{Hierarchy|{{PAGENAME}}}}
@@ Line 4: / Line 6: @@
 |LipidBank=XPR1771
 |LipidMaps=LMFA03010101
-|SysName=9a,15S-dihydroxy-11-oxo-prosta-5Z,12E-dien-1-oic acid
+|SysName=(9alpha,15S) -Dihydroxy-11-oxo-prosta- (cis-5,trans-12) -dien-1-oic acid
-|Common Name=&&d12-Prostaglandin D2&&
+|Common Name=&&delta12- Prostaglandin D_2&&(9alpha,15S) -Dihydroxy-11-oxo-prosta- (5Z,12E) -dien-1-oic acid&&
+|Source=
+|Chemical Synthesis=
+|Metabolism=
+|Biological Activity= delta 12-PGD2 is catalyzed to  delta 12-PGJ2, which has antimitotic and carcinogenic activities.[[Reference:Kato_T:Fukushima_M:Kurozumi_S:Noyori_R:,Cancer Res.,1986,46,3538|{{RelationTable/GetFirstAuthor|Reference:Kato_T:Fukushima_M:Kurozumi_S:Noyori_R:,Cancer Res.,1986,46,3538}}]][[Reference:Fukushima_M:,Eicosanoids,1990,3,189|{{RelationTable/GetFirstAuthor|Reference:Fukushima_M:,Eicosanoids,1990,3,189}}]]
 }}
+{{Lipid/Footer}}